Validity of new methods to evaluate renal function in cancer patients treated with cisplatin-Reference-Cited by-同舟云学术

Validity of new methods to evaluate renal function in cancer patients treated with cisplatin

Published:2016-01-20 Issue:2 Volume:77 Page:281-288
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Funakoshi Yohei,Fujiwara Yutaka,Kiyota Naomi,Mukohara Toru,Shimada Takanobu,Toyoda Masanori,Imamura Yoshinori,Chayahara Naoko,Tomioka Hideo,Umezu Michio,Otsuki Naoki,Nibu Ken-ichi,Minami Hironobu

Funder

the Japanese Ministry of Labour, Health and Welfare

the Japanese Ministry of Education, Culture, Science and Technology

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-016-2966-1.pdf

Reference32 articles.

1. Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol Off J Am Soc Clin Oncol 16(4):1310–1317

2. Azzoli CG, Kris MG, Pfister DG (2007) Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer–an old rivalry renewed. J Natl Cancer Inst 99(11):828–829. doi: 10.1093/jnci/djk222

3. Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA, Loehrer PJ (1987) Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316(23):1435–1440. doi: 10.1056/NEJM198706043162302

4. Hartmann JT, Lipp HP (2003) Toxicity of platinum compounds. Expert Opin Pharmacother 4(6):889–901. doi: 10.1517/14656566.4.6.889

5. Sastry J, Kellie SJ (2005) Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatr Hematol Oncol 22(5):441–445. doi: 10.1080/08880010590964381

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Glomerular Filtration Rate in Patients with Cancer: A Statement from the American Society of Onco-Nephrology;Clinical Journal of the American Society of Nephrology;2024-06-07

2. Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022;Clinical and Experimental Nephrology;2023-10-25

3. Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?;Cancer Treatment Reviews;2023-09

4. Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022;International Journal of Clinical Oncology;2023-06-29

5. Adjustment of creatinine clearance for carboplatin dosing in Calvert's formula and clinical efficacy for lung cancer;Cancer Medicine;2023-06-23